Korean pharmas developed 9 products of 8 types biosimilars like Remsima
It was reported 9 biologic products of 8 types were developed by Korean pharmaceutical companies, such as Celltrion with the rheumatoid arthritis therapy ‘Remsima Inj.’
According to the Ministry of Food and Drug Safety(MFDS), 13 biosimilar products of total 10 types have been approved in Korea e...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
